PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 1, 1996Blood Coagulation & Fibrinolysis774 citations

Platelet size

View Full Paper
PBPhilip M. BathRBR J Butterworth

Key Points

  • The research aims to explore the significance of mean platelet volume (MPV) as a marker for platelet function and its correlations with various vascular conditions.
  • Measurement of MPV using sodium citrate as the anticoagulant in clinical hematology analysers.
  • Comparative analysis of MPV levels in states of hypercholesterolaemia, diabetes mellitus, and other vascular conditions.
  • Epidemiological studies to ascertain MPV's role as a risk factor for vascular disease.
  • MPV is significantly elevated in conditions such as acute myocardial infarction, acute ischemic stroke, and pre-eclampsia.
  • Elevated MPV is associated with poorer outcomes after myocardial infarction and restenosis post-coronary angioplasty.
  • MPV levels correlate with platelet function markers including aggregation and thromboxane synthesis.

Abstract

Platelet volume is a marker of platelet function and activation. It is readily measured as mean platelet volume (MPV) by clinical haematology analysers using sodium citrate as the anticoagulant. Measurement in EDTA can be unreliable since MPV increases significantly in a time-dependent manner. MPV correlates with platelet function and activation, whether measured as aggregation, thromboxane synthesis, beta-thromboglobulin release, procoagulant function, or adhesion molecule expression. MPV is increased in certain vascular risk factor states, including hypercholesterolaemia and diabetes mellitus, but not essential hypertension. It is increased in acute myocardial infarction, acute ischaemic stroke, pre-eclampsia and renal artery stenosis. Importantly, an elevated MPV predicts a poor outcome following myocardial infarction, restenosis following coronary angioplasty, and the development of pre-eclampsia. Research into the epidemiology of MPV is now required to determine whether thrombomegaly is a risk factor for developing vascular disease. Similarly, the physiological mechanisms which regulate MPV within the megakaryocyte need to be elucidated. Whether MPV ever becomes a routinely requested test remains to be seen but changes in methodology will be required first.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Bath et al. (1996) studied this question.

synapsesocial.com/papers/69d570ae75589c71d767de3fhttps://doi.org/10.1097/00001721-199603000-00011
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Mean platelet volume as diagnostic and therapeutic marker of risk and prognosis of heart disease2018
  2. 2Mean Platelet Volume Predicts Severe COVID-19 Illness2021 · 29 citations
  3. 3The Relationship Between Changes in Mean Platelet Volume and Mortality in Non–ST-Segment Elevation Myocardial Infarction2016 · 1 citations
  4. 4Mean platelet volume and coronary artery disease2019 · 60 citations
  5. 5Increased mean platelet volume in patients with acute coronary syndromes.2009 · 67 citations